Your browser doesn't support javascript.
loading
Reexamination of the chromium-51-labeled posttransfusion red blood cell recovery method.
Francis, Richard O; Mahajan, Sonia; Rapido, Francesca; La Carpia, Francesca; Soffing, Mark; Divgi, Chaitanya; Yeh, Randy; Mintz, Akiva; Leslie, Lenhurst; Agrest, Irina; Karafin, Matthew S; Ginzburg, Yelena; Shaz, Beth H; Spitalnik, Steven L; Schwartz, Joseph; Thomas, Tiffany; Fu, Xiaoyun; Amireault, Pascal; Buffet, Pierre; Zimring, James C; D'Alessandro, Angelo; Hod, Eldad A.
Afiliação
  • Francis RO; Pathology and Cell Biology, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York.
  • Mahajan S; Nuclear Medicine, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York.
  • Rapido F; Pathology and Cell Biology, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York.
  • La Carpia F; Pôle Neuroscience Tête et Cou, Département d'Anesthésie -Réanimation Hôpital Gui de Chauliac- Centre Hospitalier Universitaire, Montpellier, France.
  • Soffing M; Pathology and Cell Biology, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York.
  • Divgi C; Nuclear Medicine, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York.
  • Yeh R; Nuclear Medicine, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York.
  • Mintz A; Nuclear Medicine, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York.
  • Leslie L; Nuclear Medicine, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York.
  • Agrest I; Nuclear Medicine, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York.
  • Karafin MS; Nuclear Medicine, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York.
  • Ginzburg Y; Versiti Medical Sciences Institute, Milwaukee, Wisconsin.
  • Shaz BH; Division of Hematology Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Spitalnik SL; New York Blood Center, New York, New York.
  • Schwartz J; Pathology and Cell Biology, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York.
  • Thomas T; Pathology and Cell Biology, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York.
  • Fu X; Pathology and Cell Biology, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York.
  • Amireault P; BloodWorks Northwest, Seattle, Washington.
  • Buffet P; Biologie Intégrée du Globule Rouge UMR_S1134, INSERM, Univ. Paris Diderot, Sorbonne Paris Cité, Univ. de la Réunion, Univ. des Antilles, Institut National de la Transfusion Sanguine, Laboratory of Excellence GR-Ex, Paris, France.
  • Zimring JC; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications U1163/CNRS ERL 8254, INSERM, CNRS, Univ Paris Descartes, Sorbonne Paris Cité, Paris, France.
  • D'Alessandro A; Biologie Intégrée du Globule Rouge UMR_S1134, INSERM, Univ. Paris Diderot, Sorbonne Paris Cité, Univ. de la Réunion, Univ. des Antilles, Institut National de la Transfusion Sanguine, Laboratory of Excellence GR-Ex, Paris, France.
  • Hod EA; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Transfusion ; 59(7): 2264-2275, 2019 07.
Article em En | MEDLINE | ID: mdl-31002399
BACKGROUND: The chromium-51-labeled posttransfusion recovery (PTR) study has been the gold-standard test for assessing red blood cell (RBC) quality. Despite guiding RBC storage development for decades, it has several potential sources for error. METHODS: Four healthy adult volunteers each donated an autologous, leukoreduced RBC unit, aliquots were radiolabeled with technetium-99m after 1 and 6 weeks of storage, and then infused. Subjects were imaged by single-photon-emission computed tomography immediately and 4 hours after infusion. Additionally, from subjects described in a previously published study, adenosine triphosphate levels in transfusates infused into 52 healthy volunteers randomized to a single autologous, leukoreduced, RBC transfusion after 1, 2, 3, 4, 5, or 6 weeks of storage were correlated with PTR and laboratory parameters of hemolysis. RESULTS: Evidence from one subject imaged after infusion of technetium-99m-labeled RBCs suggests that, in some individuals, RBCs may be temporarily sequestered in the liver and spleen immediately following transfusion and then subsequently released back into circulation; this could be one source of error leading to PTR results that may not accurately predict the true quantity of RBCs cleared by intra- and/or extravascular hemolysis. Indeed, adenosine triphosphate levels in the transfusates correlated more robustly with measures of extravascular hemolysis in vivo (e.g., serum iron, indirect bilirubin, non-transferrin-bound iron) than with PTR results or measures of intravascular hemolysis (e.g., plasma free hemoglobin). CONCLUSIONS: Sources of measurement error are inherent in the chromium-51 PTR method. Transfusion of an entire unlabeled RBC unit, followed by quantifying extravascular hemolysis markers, may more accurately measure true posttransfusion RBC recovery.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preservação de Sangue / Radioisótopos de Cromo / Transfusão de Eritrócitos / Eritrócitos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preservação de Sangue / Radioisótopos de Cromo / Transfusão de Eritrócitos / Eritrócitos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article